CSTL CASTLE BIOSCIENCES INC

8-K Current Report

Filed: February 26, 2026

Health Care

Services-Medical Laboratories

CASTLE BIOSCIENCES INC (CSTL) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 results announced Feb 26, 2026; details in Exhibit 99.1
• Filing covers period ending Dec 31, 2025 — no financials disclosed in 8-K body itself

+1 more insights

Item 7.01 · Regulation FD Disclosure

• Investor slide presentation published Feb 26, 2026, available as Exhibit 99.2
• Management may reference these slides in future investor/analyst meetings, signaling ongoing strategic messaging

Get deeper insights on CASTLE BIOSCIENCES INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.